BCL2 and B-cell non-Hodgkin lymphoma: The initial diagnostic approach of aggressive peripheral B-cell lymphomas should include the evaluation of the morphological and immunophenotypic characteristics including, as previously discussed, the COO and the percentage of MYC and BCL2-positive neoplastic cells.